Cysticercosis of the central nervous system
- 1 October 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Infectious Diseases
- Vol. 24 (5), 423-427
- https://doi.org/10.1097/qco.0b013e32834a1b20
Abstract
Purpose of review Taenia solium neurocysticercosis (NCC) has been long recognized as an important cause of neurological morbidity in most of the world. Unwarranted generalization of diagnostic and treatment recommendations made it difficult to assess individual prognosis and responses for each type of NCC. Understanding of the main clinical presentations (dependent on number, location, size, and stage of parasites, as well as on the immune response of the host) allows a better view of treatment options and expected outcomes. Recent findings Current treatment options are still limited and involve symptomatic agents, antiparasitic agents, or surgery. The importance of adequate symptomatic management, the potential for improved antiparasitic treatment regimes, in particular combination therapy, and the increasingly important role of minimally invasive neurosurgery are also reviewed in this article. Summary Treatment decisions in NCC should be individualized in relation to the type of NCC. Initial measures should focus on the symptomatic management before considering antiparasitic therapy when appropriate. Appropriate patient categorization, new antiparasitic regimes, and minimally invasive surgery are improving the prognosis of patients with NCC.Keywords
This publication has 40 references indexed in Scilit:
- Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosisBritish Journal of Clinical Pharmacology, 2011
- Neurocysticercosis and its impact on crude prevalence rate of epilepsy in an Indian communityNeurology India, 2011
- A Systematic Review of the Frequency of Neurocyticercosis with a Focus on People with EpilepsyPLoS Neglected Tropical Diseases, 2010
- NeurocysticercosisNeurology, 2010
- Cysticercosis and neurocysticercosis as pathogens affecting the nervous systemProgress in Neurobiology, 2010
- Cognitive impairment and dementia in neurocysticercosisNeurology, 2010
- Treatment of neurocysticercosisNeurology, 2006
- Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary studyJournal of Neurosurgery, 1996
- A prognostic classification of cerebral cysticercosis: therapeutic implications.Journal of Neurology, Neurosurgery & Psychiatry, 1986
- Cysticercosis as seen in the British Army, with special reference to the production of epilepsyTransactions of the Royal Society of Tropical Medicine and Hygiene, 1934